Organization Profile

You just read:

Merck Serono Announces New Publication of Results of the Phase III START Trial Investigating Tecemotide in Non-Small Cell Lung Cancer in The Lancet Oncology

News provided by

Merck Serono

Dec 09, 2013, 05:35 ET